Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.40 USD
−240.05 M USD
69.56 M USD
77.83 M
About ADC Therapeutics SA
Sector
CEO
Ameet Mallik
Headquarters
Epalinges
Website
Founded
2011
ISIN
CH0499880968
FIGI
BBG00Q6Q3QX1
ADC Therapeutics SA is a clinical-stage biotechnology company. It engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland.
trading it to $30With an ADC platform validated by the FDA approval of ZYNLONTA® and a deep understanding of the oncology treatment landscape, ADCT is working to address significant unmet medical needs and improve outcomes for those with difficult-to-treat hematological cancers and solid tumors.
ADCT: Inverse Head and Shoulders. ADCT broke inverse H&S in NOV. 20. At this moment should be only testing resistance. Stop loss at $32.50 and target is $42.00
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ADCT is 1.98 USD — it has decreased by −3.88% in the past 24 hours. Watch ADC Therapeutics SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange ADC Therapeutics SA stocks are traded under the ticker ADCT.
ADCT stock has fallen by −32.88% compared to the previous week, the month change is a −36.74% fall, over the last year ADC Therapeutics SA has showed a 182.86% increase.
We've gathered analysts' opinions on ADC Therapeutics SA future price: according to them, ADCT price has a max estimate of 10.00 USD and a min estimate of 6.00 USD. Watch ADCT chart and read a more detailed ADC Therapeutics SA stock forecast: see what analysts think of ADC Therapeutics SA and suggest that you do with its stocks.
ADCT reached its all-time high on Jul 2, 2020 with the price of 56.59 USD, and its all-time low was 0.36 USD and was reached on Nov 13, 2023. View more price dynamics on ADCT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ADCT stock is 7.95% volatile and has beta coefficient of 2.48. Track ADC Therapeutics SA stock price on the chart and check out the list of the most volatile stocks — is ADC Therapeutics SA there?
Today ADC Therapeutics SA has the market capitalization of 191.44 M, it has decreased by −26.95% over the last week.
Yes, you can track ADC Therapeutics SA financials in yearly and quarterly reports right on TradingView.
ADC Therapeutics SA is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
ADCT earnings for the last quarter are −0.42 USD per share, whereas the estimation was −0.40 USD resulting in a −6.33% surprise. The estimated earnings for the next quarter are −0.43 USD per share. See more details about ADC Therapeutics SA earnings.
ADC Therapeutics SA revenue for the last quarter amounts to 18.46 M USD, despite the estimated figure of 18.43 M USD. In the next quarter, revenue is expected to reach 18.73 M USD.
ADCT net income for the last quarter is −43.97 M USD, while the quarter before that showed −36.54 M USD of net income which accounts for −20.32% change. Track more ADC Therapeutics SA financial stats to get the full picture.
No, ADCT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 162.00 employees. See our rating of the largest employees — is ADC Therapeutics SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ADC Therapeutics SA EBITDA is −133.07 M USD, and current EBITDA margin is −231.62%. See more stats in ADC Therapeutics SA financial statements.
Like other stocks, ADCT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ADC Therapeutics SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ADC Therapeutics SA technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ADC Therapeutics SA stock shows the sell signal. See more of ADC Therapeutics SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.